9-101640082-A-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_133445.3(GRIN3A):c.2353-11681T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.101 in 152,200 control chromosomes in the GnomAD database, including 923 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.10 ( 923 hom., cov: 32)
Consequence
GRIN3A
NM_133445.3 intron
NM_133445.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0660
Publications
2 publications found
Genes affected
GRIN3A (HGNC:16767): (glutamate ionotropic receptor NMDA type subunit 3A) This gene encodes a subunit of the N-methyl-D-aspartate (NMDA) receptors, which belong to the superfamily of glutamate-regulated ion channels, and function in physiological and pathological processes in the central nervous system. This subunit shows greater than 90% identity to the corresponding subunit in rat. Studies in the knockout mouse deficient in this subunit suggest that this gene may be involved in the development of synaptic elements by modulating NMDA receptor activity. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.163 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GRIN3A | ENST00000361820.6 | c.2353-11681T>G | intron_variant | Intron 3 of 8 | 1 | NM_133445.3 | ENSP00000355155.3 | |||
| ENSG00000299588 | ENST00000764873.1 | n.223+33707A>C | intron_variant | Intron 2 of 4 | ||||||
| ENSG00000299588 | ENST00000764875.1 | n.198+33707A>C | intron_variant | Intron 2 of 3 |
Frequencies
GnomAD3 genomes AF: 0.101 AC: 15321AN: 152082Hom.: 921 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
15321
AN:
152082
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.101 AC: 15350AN: 152200Hom.: 923 Cov.: 32 AF XY: 0.103 AC XY: 7629AN XY: 74398 show subpopulations
GnomAD4 genome
AF:
AC:
15350
AN:
152200
Hom.:
Cov.:
32
AF XY:
AC XY:
7629
AN XY:
74398
show subpopulations
African (AFR)
AF:
AC:
6905
AN:
41524
American (AMR)
AF:
AC:
1314
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
300
AN:
3470
East Asian (EAS)
AF:
AC:
274
AN:
5172
South Asian (SAS)
AF:
AC:
487
AN:
4826
European-Finnish (FIN)
AF:
AC:
1072
AN:
10594
Middle Eastern (MID)
AF:
AC:
51
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4539
AN:
68000
Other (OTH)
AF:
AC:
212
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
685
1370
2055
2740
3425
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
335
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.